Cargando…
Molecular profiling of allergen-antibody IgE might decide about the efficacy of allergen immunotherapy in a patient with atopic dermatitis and allergy to house dust mites
INTRODUCTION: Allergen immunotherapy (AIT) has no clear recommendation for atopic dermatitis (AD). AIM: To evaluate the effect of AIT on house dust mites (HDM) in AD patients sensitised to HDM with different baseline molecular profiles of antigens. MATERIAL AND METHODS: In this placebo-controlled st...
Autores principales: | Bogacz-Piaseczyńska, Agnieszka, Bożek, Andrzej, Pastuszczak, Maciej, Zalejska-Fiolka, Jolanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485758/ https://www.ncbi.nlm.nih.gov/pubmed/37692262 http://dx.doi.org/10.5114/ada.2023.129456 |
Ejemplares similares
-
The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites
por: Bogacz-Piaseczyńska, Agnieszka, et al.
Publicado: (2022) -
Non-IgE-reactive allergen peptides deteriorate the skin barrier in house dust mite-sensitized atopic dermatitis patients
por: Pfisterer, Karin, et al.
Publicado: (2023) -
The Indoor Level of House Dust Mite Allergen Is Associated with Severity of Atopic Dermatitis in Children
por: Kim, Jihyun, et al.
Publicado: (2013) -
Adding a biologic to allergen immunotherapy increases treatment efficacy
por: Bożek, Andrzej, et al.
Publicado: (2023) -
Safety of Accelerated Schedules of Subcutaneous Allergen Immunotherapy with House Dust Mite Extract in Patients with Atopic Dermatitis
por: Kim, Myoung-Eun, et al.
Publicado: (2011)